Nathalie Wurtz Selected Research

Nathalie Wurtz Research Topics

11	Malaria 09/2015 - 06/2009
3	COVID-19 01/2022 - 06/2021
2	Falciparum Malaria (Plasmodium falciparum Malaria) 11/2013 - 05/2012
1	Burns 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Atopic Dermatitis (Atopic Eczema) 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2021
1	COVID-19 rebound 01/2021
1	Reinfection 05/2012
1	Infections 09/2010
1	Flavivirus Infections 09/2010

6	Quinine (Quinson)FDA Link 09/2015 - 01/2010
5	Doxycycline (Periostat)FDA LinkGeneric 09/2015 - 01/2010
2	RNA (Ribonucleic Acid)IBA 08/2021 - 01/2021
2	Indicators and Reagents (Reagents)IBA 06/2021 - 01/2021
2	ArtesunateIBA 09/2015 - 06/2013
2	artemisinin (artemisinine)IBA 03/2013 - 05/2010
2	Mefloquine (Lariam)FDA LinkGeneric 03/2013 - 07/2010
2	Antimalarials (Antimalarial Agents)IBA 05/2010 - 06/2009
1	SolutionsIBA 01/2022
1	WastewaterIBA 01/2021
1	Viral RNAIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2015
1	Chloroquine (Aralen)FDA LinkGeneric 03/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2013
1	Lumefantrine FDA Link 03/2013
1	Amodiaquine (Camoquin)FDA Link 03/2013
1	desethylamodiaquineIBA 03/2013
1	artenimol (dihydroartemisinin)IBA 03/2013
1	AntigensIBA 01/2013
1	proguanil drug combination atovaquone (malarone)FDA Link 05/2012
1	Cytochromes b (Cytochrome b)IBA 05/2012
1	Antiviral Agents (Antivirals)IBA 09/2010
1	VaccinesIBA 09/2010
1	Atorvastatin (Lipitor)FDA Link 07/2010
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 06/2009
1	EnzymesIBA 06/2009

4	Chemoprevention 09/2015 - 01/2010
1	Personal Protective Equipment 06/2021
1	Therapeutics 03/2013